Exp Clin Endocrinol Diabetes 1987; 89(1): 55-60
DOI: 10.1055/s-0029-1210627
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Thyrotropin-Releasing Hormone Reduces the Plasma Levels of β-Endorphin-like Immunoreactivity in Rats

T. Mitsuma, T. Nogimori, D. H. Sun, M. Chaya
  • Fourth Department of Internal Medicine, Aichi Medical University, Nagakute, Aichi/Japan
Weitere Informationen

Publikationsverlauf

1986

Publikationsdatum:
16. Juli 2009 (online)

Summary

Effects of thyrotropin-releasing hormone (TRH) on the plasma β-endorphin-like immunoreactivity (β-Ep-LI) levels in rats have been studied. TRH (10 mg/kg) were injected i.V., and the animals were serially decapitated. The plasma β-Ep-LI levels were measured by radioimmunoassay. Effects of TRH on β-Ep-LI release from the anterior pituitary were also investigated by means of an in vitro experiment.

The β-Ep-LI content in the hypothalamus, pituitary gland or adrenal gland did not change significantly after TRH injection. The plasma β-Ep-LI levels decreased significantly in a dose-related manner with a nadir at 40 min after the injection. In the hypophysectomized rats, the plasma β-Ep-LI levels were lower than that of the control, and did not change significantly after TRH injection. β-Ep-LI release from anterior pituitary in vitro significantly decreased after the addition of TRH to medium.

These findings suggest that TRH may act on the pituitary gland to reduce plasma β-Ep-LI levels in rats.